ArticleMarine biotechnology (New York, N.Y.)2025

Prediction and Assessment of Anticancer, Antiproliferative, Pharmacokinetic Properties, and Human Serum Albumin Binding Propensity of a New Bioactive Marine Cyclic Dipeptide from Exiguobacterium profundum.

Sriram Shankar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.